Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
This study is currently recruiting participants.
Verified by American Medical Systems, February 2008
Sponsored by: American Medical Systems
Information provided by: American Medical Systems
ClinicalTrials.gov Identifier: NCT00388947
  Purpose

Observational (meaning that we are simply collecting whatever information the surgeon typically collects when they see their patients; there is no change to the care the patient receives as a result of being part of the registry) data collection on the surgical outcomes of AMS prolapse products; we predict that patients will be significantly improved as a result of the surgery.


Condition Intervention
Vaginal Prolapse
Device: AMS Prolapse Products (ex: Perigee, Apogee, Straight-In)

MedlinePlus related topics: Pelvic Support Problems
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: The Prolapse Registry: A Prospective Observational Study of Short- and Long-Term Patient Outcomes Following Use of AMS Surgical Devices for the Repair of Female Genital Prolapse

Further study details as provided by American Medical Systems:

Estimated Enrollment: 1000
Study Start Date: September 2006
Estimated Study Completion Date: September 2008
Detailed Description:

The Prolapse Registry is an observational study of patients who are implanted with AMS devices for the surgical repair of female pelvic prolapse. The registry will follow patients post-operatively for up to 2 years and will collect demographic, clinical, surgical, safety, and patient outcomes data.

The registry is a web-based system in which surgeons enter patient information with regard to their prolapse surgery. All information entered is de-identified (no names, no date of birth, no date of surgery, etc).

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Female at least 21 years old
  • Has pelvic organ prolapse requiring surgical repair
  • Receives at least one of the AMS Prolapse Repair devices in the treatment of their pelvic organ prolapse

Exclusion Criteria:

  • Is contraindicated for an AMS Prolapse Repair per the product's Instruction for Use.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00388947

Contacts
Contact: Deborah Strohmeyer, MS 952-930-6061 Deborah.Strohmeyer@ammd.com

Locations
United States, Massachusetts
Samuel Zylstra, MD Recruiting
Whitinsville, Massachusetts, United States, 01588
Contact: Samuel Zylstra, MD     508-234-6260     szylstra@milreg.org    
Sponsors and Collaborators
American Medical Systems
Investigators
Principal Investigator: Samuel Zylstra, MD Whitinsville Medical Center
  More Information

Responsible Party: AMS ( Deborah Strohmeyer, Clinical Study Coordinator )
Study ID Numbers: 1012
Study First Received: October 16, 2006
Last Updated: February 20, 2008
ClinicalTrials.gov Identifier: NCT00388947  
Health Authority: United States: Institutional Review Board

Keywords provided by American Medical Systems:
vaginal prolapse
cystocele
rectocele
enterocele
apical prolapse
vaginal vault prolapse

Study placed in the following topic categories:
Pathological Conditions, Anatomical
Rectocele
Cystocele
Uterine Prolapse
Gastrointestinal Diseases
Urinary Bladder Diseases
Uterine Diseases
Intestinal Diseases
Prolapse
Rectal Diseases
Genital Diseases, Female
Digestive System Diseases
Rectal Prolapse

ClinicalTrials.gov processed this record on January 16, 2009